Translating Drug Substance into Clinical-Ready Dosage Forms
Sai Life Sciences develops formulations that enable small molecule NCEs to progress from laboratory understanding to clinical evaluation.
Our teams apply physicochemical profiling, particle science integration, and biopharmaceutic principles to design stable, manufacturable dosage forms. Early formulation strategies are aligned with drug substance attributes to minimize reformulation risk and support clinical advancement. From pre-formulation through clinical supply, formulation development is integrated with analytical and manufacturing teams to ensure continuity and control.
Our Capabilities
The Sai Difference
Formulation Development at Sai bridges drug substance science and patient-ready delivery, supporting efficient progression into clinical studies. We also bring a unified framework that integrates formulation science, analytical strength, and development-scale operations. Our approach ensures consistency, scalability, and patient-centric design across every program.